Thomas Moore is listed as an executive officer and director on 12 SEC Form D filings by 2 issuers between Oct 2009 and Jun 2017: Nuvolo Technologies Corp (Paramus, NJ — other technology — 2017; $31M reported sold to 11 investors) and Ayala Pharmaceuticals, Inc. (Monmouth Junction, NJ — biotechnology — 2009–2012; $11.1M reported sold to 29 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 8 years. Across those companies the filings report $42.1M sold in total.
Listed alongside James Patton (11 shared filings), John Rothman (11 shared filings), Richard Berman (11 shared filings), Roni A. Appel (11 shared filings), Thomas McKearn (11 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 SEC releases, 5 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for Thomas Moore and found 14 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.